9 -

9 - Waddell T, Chau I, Cunningham D et al. Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial.[Erratum appears in Lancet Oncol. 2013 Jun;14(7):e254 Note: Frances, Alicia [corrected to Okines, Alicia Frances Clare]]. Lancet Oncology. 2013;14(6):481-9 [link]